BioSpace News Archive

MAIA Biotechnology, Inc., a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, announced that independent director Mr. Stan V. Smith, Ph.D. made an individual purchase of 170,940 shares of the Company’s common stock as part of the Company’s recent private placement of common stock and warrants.

Retrieve Medical Holdings, Inc. (RMHI), the developer of Retrieve Dx, a real-time, cloud-based CDI (Clinical Documentation Integrity) application that improves physician documentation, today announced a study showing a substantial increase in documented diagnoses using the Retrieve software.

Fresenius Medical Care today published its joint 2023 Annual Report and Non-financial Group Report, available digitally on the corporate website.

Astellas Pharma Inc. today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending approval of XTANDI.

Telomir Pharmaceuticals, Inc.(Nasdaq:TELO) (“Telomir” or the “Company”) today announced that Telomir and Danielle R. Baker, Ph.D., of Frontage Laboratories will present a scientific poster presentation at the Global Longevity Federation Conference in Las Vegas on March 26th at 2 pm EDT.